Clinical Trials
6 trialsNCT05093335 2026-02-05
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03335670 2025-07-14
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
University of Iowa
Phase EARLY_PHASE1 Active not recruiting
NCT06086327 2023-10-17
Application of 68Ga-Pentixafor PET/CT for Thymoma
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT04504526 2023-09-15
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT05364177 2022-05-06
68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT03436342 2019-12-27
Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown